LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 4 of total 4

Search options

  1. Article ; Online: T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses.

    Ogbe, Ane / Kronsteiner, Barbara / Skelly, Donal T / Pace, Matthew / Brown, Anthony / Adland, Emily / Adair, Kareena / Akhter, Hossain Delowar / Ali, Mohammad / Ali, Serat-E / Angyal, Adrienn / Ansari, M Azim / Arancibia-Cárcamo, Carolina V / Brown, Helen / Chinnakannan, Senthil / Conlon, Christopher / de Lara, Catherine / de Silva, Thushan / Dold, Christina /
    Dong, Tao / Donnison, Timothy / Eyre, David / Flaxman, Amy / Fletcher, Helen / Gardner, Joshua / Grist, James T / Hackstein, Carl-Philipp / Jaruthamsophon, Kanoot / Jeffery, Katie / Lambe, Teresa / Lee, Lian / Li, Wenqin / Lim, Nicholas / Matthews, Philippa C / Mentzer, Alexander J / Moore, Shona C / Naisbitt, Dean J / Ogese, Monday / Ogg, Graham / Openshaw, Peter / Pirmohamed, Munir / Pollard, Andrew J / Ramamurthy, Narayan / Rongkard, Patpong / Rowland-Jones, Sarah / Sampson, Oliver / Screaton, Gavin / Sette, Alessandro / Stafford, Lizzie / Thompson, Craig / Thomson, Paul J / Thwaites, Ryan / Vieira, Vinicius / Weiskopf, Daniela / Zacharopoulou, Panagiota / Turtle, Lance / Klenerman, Paul / Goulder, Philip / Frater, John / Barnes, Eleanor / Dunachie, Susanna

    Nature communications

    2021  Volume 12, Issue 1, Page(s) 2055

    Abstract: ... a range of T cell assays that differentially capture immune function to characterise SARS-CoV-2 responses ... Identification of protective T cell responses against SARS-CoV-2 requires distinguishing people ... cell populations. The detection of T cell responses to SARS-CoV-2 is therefore critically dependent ...

    Abstract Identification of protective T cell responses against SARS-CoV-2 requires distinguishing people infected with SARS-CoV-2 from those with cross-reactive immunity to other coronaviruses. Here we show a range of T cell assays that differentially capture immune function to characterise SARS-CoV-2 responses. Strong ex vivo ELISpot and proliferation responses to multiple antigens (including M, NP and ORF3) are found in 168 PCR-confirmed SARS-CoV-2 infected volunteers, but are rare in 119 uninfected volunteers. Highly exposed seronegative healthcare workers with recent COVID-19-compatible illness show T cell response patterns characteristic of infection. By contrast, >90% of convalescent or unexposed people show proliferation and cellular lactate responses to spike subunits S1/S2, indicating pre-existing cross-reactive T cell populations. The detection of T cell responses to SARS-CoV-2 is therefore critically dependent on assay and antigen selection. Memory responses to specific non-spike proteins provide a method to distinguish recent infection from pre-existing immunity in exposed populations.
    MeSH term(s) Antiviral Agents/pharmacology ; CD4-Positive T-Lymphocytes/immunology ; CD8-Positive T-Lymphocytes/immunology ; COVID-19/epidemiology ; COVID-19/immunology ; COVID-19/virology ; Cell Proliferation ; Cross Reactions/immunology ; Cytokines/metabolism ; HEK293 Cells ; Health Personnel ; Humans ; Immunoassay/methods ; Immunoglobulin G/immunology ; Immunologic Memory ; Interferon-gamma/metabolism ; Pandemics ; Peptides/metabolism ; SARS-CoV-2/drug effects ; SARS-CoV-2/physiology ; T-Lymphocytes/immunology
    Chemical Substances Antiviral Agents ; Cytokines ; Immunoglobulin G ; Peptides ; Interferon-gamma (82115-62-6)
    Language English
    Publishing date 2021-04-06
    Publishing country England
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2553671-0
    ISSN 2041-1723 ; 2041-1723
    ISSN (online) 2041-1723
    ISSN 2041-1723
    DOI 10.1038/s41467-021-21856-3
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

    Ane Ogbe / Barbara Kronsteiner / Donal T. Skelly / Matthew Pace / Anthony Brown / Emily Adland / Kareena Adair / Hossain Delowar Akhter / Mohammad Ali / Serat-E Ali / Adrienn Angyal / M. Azim Ansari / Carolina V. Arancibia-Cárcamo / Helen Brown / Senthil Chinnakannan / Christopher Conlon / Catherine de Lara / Thushan de Silva / Christina Dold /
    Tao Dong / Timothy Donnison / David Eyre / Amy Flaxman / Helen Fletcher / Joshua Gardner / James T. Grist / Carl-Philipp Hackstein / Kanoot Jaruthamsophon / Katie Jeffery / Teresa Lambe / Lian Lee / Wenqin Li / Nicholas Lim / Philippa C. Matthews / Alexander J. Mentzer / Shona C. Moore / Dean J. Naisbitt / Monday Ogese / Graham Ogg / Peter Openshaw / Munir Pirmohamed / Andrew J. Pollard / Narayan Ramamurthy / Patpong Rongkard / Sarah Rowland-Jones / Oliver Sampson / Gavin Screaton / Alessandro Sette / Lizzie Stafford / Craig Thompson / Paul J. Thomson / Ryan Thwaites / Vinicius Vieira / Daniela Weiskopf / Panagiota Zacharopoulou / Oxford Immunology Network Covid-19 Response T Cell Consortium / Oxford Protective T Cell Immunology for COVID-19 (OPTIC) Clinical Team / Lance Turtle / Paul Klenerman / Philip Goulder / John Frater / Eleanor Barnes / Susanna Dunachie

    Nature Communications, Vol 12, Iss 1, Pp 1-

    2021  Volume 14

    Abstract: Understanding the immune response to SARS-CoV-2 is dependent on being able to distinguish COVID-19 ... of antigens and whether an ICS, ELISPOT or T cell proliferation assay is used has a major effect ... immune responses from cross-reactive immune responses to other coronaviruses. Here the authors show that choice ...

    Abstract Understanding the immune response to SARS-CoV-2 is dependent on being able to distinguish COVID-19 immune responses from cross-reactive immune responses to other coronaviruses. Here the authors show that choice of antigens and whether an ICS, ELISPOT or T cell proliferation assay is used has a major effect on this discriminatory ability.
    Keywords Science ; Q
    Language English
    Publishing date 2021-04-01T00:00:00Z
    Publisher Nature Portfolio
    Document type Article ; Online
    Database BASE - Bielefeld Academic Search Engine (life sciences selection)

    More links

    Kategorien

  3. Article ; Online: T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

    Ogbe, A. / Kronsteiner, B. / Skelly, D. T. / Pace, M. / Brown, A. / Adland, E. / Adair, K. / Akhter, H. D. / Ali, M. / Ali, S.-E. / Angyal, A. / Ansari, M. A. / Arancibia-Carcamo, C. V. / Brown, H. / Chinnakannan, S. / Conlon, C. P. / de Lara, C. / de Silva, T. / Dold, C. /
    Dong, T. D. / Donnison, T. / Eyre, D. W. / Flaxman, A. / Fletcher, H. A. / Gardner, J. / Grist, J. T. / Hackstein, C.-P. / Jaruthamsophon, K. / Jeffrey, K. / Lambe, T. / Lee, L. / Li, W. / Lim, N. / Matthews, P. C. / Mentzer, A. J. / Moore, S. C. / Naisbitt, D. J. / Ogese, M. / Ogg, G. / Openshaw, P. / Pirmohamed, M. / Pollard, A. J. / Ramamurthy, N. / Rongkard, P.

    Abstract: ... existing cross-reactive T cell populations. The detection of T cell responses to SARS-CoV-2 is ... subjects and 118 seronegative subjects without known SARS-CoV-2 exposure using a range of T cell assays ... A major issue in identification of protective T cell responses against SARS-CoV-2 lies ...

    Abstract A major issue in identification of protective T cell responses against SARS-CoV-2 lies in distinguishing people infected with SARS-CoV-2 from those with cross-reactive immunity generated by exposure to other coronaviruses. We characterised SARS-CoV-2 T cell immune responses in 168 PCR-confirmed SARS-CoV-2 infected subjects and 118 seronegative subjects without known SARS-CoV-2 exposure using a range of T cell assays that differentially capture immune cell function. Strong ex vivo ELISpot and proliferation responses to multiple antigens (including M, NP and ORF3) were found in those who had been infected by SARS-CoV-2 but were rare in pre-pandemic and unexposed seronegative subjects. However, seronegative doctors with high occupational exposure and recent COVID-19 compatible illness showed patterns of T cell responses characteristic of infection, indicating that these readouts are highly sensitive. By contrast, over 90% of convalescent or unexposed people showed proliferation and cellular lactate responses to spike subunits S1/S2, indicating pre-existing cross-reactive T cell populations. The detection of T cell responses to SARS-CoV-2 is therefore critically dependent on the choice of assay and antigen. Memory responses to specific non-spike proteins provides a method to distinguish recent infection from pre-existing immunity in exposed populations.
    Keywords covid19
    Publisher MedRxiv; WHO
    Document type Article ; Online
    DOI 10.1101/2020.09.28.20202929
    Database COVID19

    Kategorien

  4. Article ; Online: T cell assays differentiate clinical and subclinical SARS-CoV-2 infections from cross-reactive antiviral responses

    Ogbe, Ane / Kronsteiner, Barbara / Skelly, Donal T / Pace, Matthew / Brown, Anthony / Adland, Emily / Adair, Kareena / Akhter, Hossain Delowar / Ali, Mohammad / Ali, Serat-E / Angyal, Adrienn / Ansari, M. Azim / Arancibia-Carcamo, Carolina V / Brown, Helen / Chinnakannan, Senthil / Conlon, Christopher P / de Lara, Catherine / de Silva, Thushan / Dold, Christina /
    Dong, Tao Dong / Donnison, Timothy / Eyre, David W / Flaxman, Amy / Fletcher, Helen A / Gardner, Joshua / Grist, James T / Hackstein, Carl-Philipp / Jaruthamsophon, Kanoot / Jeffrey, Katie / Lambe, Teresa / Lee, Lian / Li, Wenqin / Lim, Nicholas / Matthews, Philippa C / Mentzer, Alexander J / Moore, Shona C / Naisbitt, Dean J / Ogese, Monday / Ogg, Graham / Openshaw, Peter / Pirmohamed, Munir / Pollard, Andrew J / Ramamurthy, Narayan / Rongkard, Patpong / Rowland-Jones, Sarah / Sampson, Oliver L / Screaton, Gavin / Sette, Alessandro / Stafford, Lizzie / Thompson, Craig / Thomson, Paul J / Thwaites, Ryan / Vieira, Vinicius / Weiskopf, Daniela / Zacharopoulou, Panagiota / Oxford Immunology Network Covid-19 Response T cell Consortium / Oxford Protective T cell Immunology for COVID-19 (OPTIC) Clinical team / Turtle, Lance / Klenerman, Paul / Goulder, Philip / Frater, John / Barnes, Eleanor / Dunachie, Susanna

    medRxiv

    Abstract: ... existing cross-reactive T cell populations. The detection of T cell responses to SARS-CoV-2 is ... subjects and 118 seronegative subjects without known SARS-CoV-2 exposure using a range of T cell assays ... A major issue in identification of protective T cell responses against SARS-CoV-2 lies ...

    Abstract A major issue in identification of protective T cell responses against SARS-CoV-2 lies in distinguishing people infected with SARS-CoV-2 from those with cross-reactive immunity generated by exposure to other coronaviruses. We characterised SARS-CoV-2 T cell immune responses in 168 PCR-confirmed SARS-CoV-2 infected subjects and 118 seronegative subjects without known SARS-CoV-2 exposure using a range of T cell assays that differentially capture immune cell function. Strong ex vivo ELISpot and proliferation responses to multiple antigens (including M, NP and ORF3) were found in those who had been infected by SARS-CoV-2 but were rare in pre-pandemic and unexposed seronegative subjects. However, seronegative doctors with high occupational exposure and recent COVID-19 compatible illness showed patterns of T cell responses characteristic of infection, indicating that these readouts are highly sensitive. By contrast, over 90% of convalescent or unexposed people showed proliferation and cellular lactate responses to spike subunits S1/S2, indicating pre-existing cross-reactive T cell populations. The detection of T cell responses to SARS-CoV-2 is therefore critically dependent on the choice of assay and antigen. Memory responses to specific non-spike proteins provides a method to distinguish recent infection from pre-existing immunity in exposed populations.
    Keywords covid19
    Language English
    Publishing date 2020-09-29
    Publisher Cold Spring Harbor Laboratory Press
    Document type Article ; Online
    DOI 10.1101/2020.09.28.20202929
    Database COVID19

    Kategorien

To top